|
|
|
|
|
|
Onconova Therapeutic (ONTX)
|
|
2.11 +0.02 (+1.01%)
|
6/23/2017 2:31pm
|
|
Open:
|
2.12
|
Pre. Close:
|
2.09
|
|
High:
|
2.12
|
Low:
|
2.09
|
|
Volume:
|
17,831
|
Market Cap:
|
20.02M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.15 - 2.26
|
2.26 - 2.34
|
|
Low:
|
1.82 - 1.87
|
1.87 - 1.91
|
|
Close:
|
2.04 - 2.14
|
2.14 - 2.21
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 1:52:30 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 2.60 One year: 3.04
|
|
Support:
|
Support1: 1.95 Support2: 1.78
|
|
Resistance:
|
Resistance1:
2.23 Resistance2: 2.60
|
|
Pivot:
|
1.99 
|
|
Moving Averages:
|
MA(5): 2.07 MA(20): 1.98
MA(100): 2.49  MA(250): 2.89
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.05
|
|
%K %D:
|
%K(14,3): 66.45 %D(3): 62.12
|
|
RSI:
|
RSI(14): 56.08
|
|
52-Week:
|
High: 6.42
Low: 1.78 Change(%): -65.7
|
|
Average Vol(K):
|
3-Month: 205
10-Days 42
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ONTX has closed below upper band by 1.4%. Bollinger Bands are 50.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Mon, 19 Aug 2013 09:52:23 GMT
2.05
Mon, 15 May 2017 12:30:44 GMT
Onconova Therapeutics, Inc. Reports Recent Business Highlights and First ...
Mon, 05 Jun 2017 12:50:38 GMT
UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical ...
Mon, 27 Mar 2017 11:02:23 GMT
Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end ...
Tue, 04 Apr 2017 13:08:56 GMT
Onconova Therapeutics stock surges 18% on positive pre-clinical data for ...
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
